Hans Örström new Chariman of the Board | IDL Biotech
IDL Biotech

CLOSE MENU

May 2017

Hans Örström new Chariman of the Board

The annual general meeting, held 23rd of May 2017, approved the re-election of Jerker Swanstein, Max Pihlqvist, Hans Örström and Peter Brätuigam. During the statutory meeting held 24th of May 2017 Hans Örström was selected as new Chariman of the Board.

Interview with CEO Charlotte Berg

Börshajen has published an interview with Charlotte Berg, CEO at IDL Biotech.

IDL strengthens the team with Regional Manager Asia Pacific

IDL has appointed Nick Thilveris as our new Regional Manager Asia Pacific

IDL Biotech

Skip this intro